Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group
Keyword(s):
Phase Ii
◽
2012 ◽
Vol 70
(5)
◽
pp. 665-672
◽